CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 83 filers reported holding CHEMOCENTRYX INC in Q1 2017. The put-call ratio across all filers is 35.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $4,093,000 | -73.2% | 66,100 | -75.1% | 0.00% | -69.2% |
Q2 2020 | $15,254,000 | +17.4% | 265,100 | -18.0% | 0.01% | 0.0% |
Q1 2020 | $12,990,000 | -57.3% | 323,300 | -57.9% | 0.01% | -43.5% |
Q4 2019 | $30,397,000 | +245.9% | 768,581 | -40.7% | 0.02% | +228.6% |
Q3 2019 | $8,787,000 | -35.5% | 1,295,979 | -11.6% | 0.01% | -41.7% |
Q2 2019 | $13,628,000 | -13.4% | 1,465,381 | +29.3% | 0.01% | -14.3% |
Q1 2019 | $15,741,000 | +63.3% | 1,133,254 | +28.3% | 0.01% | +27.3% |
Q4 2018 | $9,638,000 | -1.3% | 883,381 | +14.4% | 0.01% | +10.0% |
Q3 2018 | $9,762,000 | -51.0% | 772,281 | -48.1% | 0.01% | -9.1% |
Q2 2018 | $19,938,000 | +90.6% | 1,488,762 | +93.5% | 0.01% | 0.0% |
Q1 2018 | $10,462,000 | +103.6% | 769,281 | -10.9% | 0.01% | +83.3% |
Q4 2017 | $5,138,000 | -25.3% | 863,581 | -6.8% | 0.01% | -25.0% |
Q3 2017 | $6,877,000 | +1.6% | 926,881 | +28.2% | 0.01% | -11.1% |
Q2 2017 | $6,769,000 | +50.8% | 723,151 | +17.3% | 0.01% | +50.0% |
Q1 2017 | $4,489,000 | +28.9% | 616,581 | +31.0% | 0.01% | 0.0% |
Q4 2016 | $3,482,000 | +191.1% | 470,581 | +137.7% | 0.01% | +200.0% |
Q3 2016 | $1,196,000 | +282.1% | 197,981 | +184.1% | 0.00% | +100.0% |
Q2 2016 | $313,000 | -25.7% | 69,681 | -58.8% | 0.00% | 0.0% |
Q1 2016 | $421,000 | +17.3% | 169,054 | +281.6% | 0.00% | 0.0% |
Q4 2015 | $359,000 | +140.9% | 44,300 | +79.4% | 0.00% | – |
Q3 2015 | $149,000 | -85.8% | 24,700 | -80.6% | 0.00% | -100.0% |
Q2 2015 | $1,048,000 | +69.9% | 127,377 | +55.9% | 0.00% | +100.0% |
Q1 2015 | $617,000 | +41.2% | 81,700 | +27.8% | 0.00% | 0.0% |
Q4 2014 | $437,000 | +42.3% | 63,923 | -6.4% | 0.00% | 0.0% |
Q3 2014 | $307,000 | -4.4% | 68,300 | +24.4% | 0.00% | 0.0% |
Q2 2014 | $321,000 | -75.8% | 54,900 | -72.5% | 0.00% | -66.7% |
Q1 2014 | $1,325,000 | -41.0% | 199,780 | -48.5% | 0.00% | -40.0% |
Q4 2013 | $2,246,000 | – | 387,880 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |